Skip to main content

Featured

RMB stock trading backed

Secretary for Financial Services & the Treasury Christopher Hui today expressed his gratitude to various listed issuers in Hong Kong for their support to the proposal of setting up a renminbi (RMB) stock trading counter.   Mr Hui stated that further to the help rendered by the Legislative Council Panel on Financial Affairs regarding the Government's proposed measures to promote the issuance and trading of RMB stocks in Hong Kong and enhance the trading mechanism, a number of listed issuers have also backed the proposal.   Such listed issuers will actively explore the feasibility of setting up a new RMB trading counter for their issued shares.   Mr Hui explained that listed issuers who indicated their support today include Hang Seng Index constituent stocks with promising turnover.   “Their participation is a vote of confidence to the development of RMB securities in Hong Kong, which will be conducive to our promotion work to other issuers, enabling Hong Kong to graduall

Vaccine data followed up

The Department of Health has been actively following up with Sinovac Biotech (Hong Kong) with a view to obtaining as soon as possible the Phase 3 clinical data of its COVID-19 vaccine for emergency use, the Government said today.   According to the latest reply from Sinovac, the company is preparing the relevant information and will submit it to the department as soon as possible.   According to the Prevention & Control of Disease (Use of Vaccines) Regulation, the Secretary for Food & Health may, under the state of public health emergency, authorise the use of COVID-19 vaccines which fulfil the criteria of safety, efficacy and quality for the purpose of vaccination programmes conducted by the Government.   The regulation also specifies the conditions and procedures which the vaccine manufacturer or its representative, importer, or wholesale dealer must follow when submitting an application for seeking authorisation for emergency use.   To complete the authorisation process in a timely and smooth manner, the department has been processing part of the information provided by Sinovac and has also requested the company to provide as soon as possible the Phase 3 clinical data it has submitted to the World Health Organization.   After receiving the necessary information and relevant clinical data, the Advisory Panel on COVID-19 Vaccines appointed by the Chief Executive will review them and make a recommendation in accordance with the regulation to ensure the relevant vaccine fulfils the criteria of safety, efficacy and quality.   The Government said it will ensure the authorised vaccines satisfy the aforesaid criteria before providing vaccination for members of the public, adding that it will adhere to the principles of openness and transparency so that the public can obtain the latest information on vaccines.
http://dlvr.it/Rrzn1C

Popular Posts